WINNERS & LOSERS: Goodwin jumps; Oxford BioMedica trims revenue view
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 4,502.00p on 24-08-2026 at 18:15:06 |
|---|---|
| Change | -90.00p -1.96% |
| Buy | 4,528.00p |
| Sell | 4,500.00p |
| Last Trade: | Buy 134.00 at 4,540.443p |
| Day's Volume: | 20,136 |
| Last Close: | 4,502.00p |
| Open: | 4,592.00p |
| ISIN: | GB0006640972 |
| Day's Range | 4,500.00p - 4,604.00p |
| 52wk Range: | 2,980.00p - 5,135.00p |
| Market Capitalisation: | £1.26b |
| VWAP: | 4,516.21514p |
| Shares in Issue: | 28.05m |
4Imprint (FOUR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 134 | 4,540.443p | SI Trade Negotiated Trade |
16:47:06 - 24-Aug-26 |
| Buy* | 13,475 | 4,502.00p | Suspected BUY Trade |
16:35:28 - 24-Aug-26 |
| Sell* | 5 | 4,500.00p | SI Trade |
16:29:51 - 24-Aug-26 |
| Sell* | 24 | 4,501.00p | SI Trade |
16:29:30 - 24-Aug-26 |
| Sell* | 87 | 4,510.00p | Automatic Execution |
16:29:30 - 24-Aug-26 |
| Sell* | 19 | 4,512.00p | Automatic Execution |
16:29:30 - 24-Aug-26 |
| Sell* | 10 | 4,510.00p | Automatic Execution |
16:29:19 - 24-Aug-26 |
| Sell* | 10 | 4,512.00p | Automatic Execution |
16:29:19 - 24-Aug-26 |
| Sell* | 10 | 4,514.00p | Automatic Execution |
16:29:19 - 24-Aug-26 |
| Sell* | 19 | 4,514.00p | Automatic Execution |
16:29:19 - 24-Aug-26 |
4Imprint (FOUR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Aug 2026 7:00 am | RNS | Half-year Financial Report |
| 30th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 29th Jun 2026 1:40 pm | RNS | Block Listing Interim Review |
| 9th Jun 2026 1:58 pm | RNS | Holding(s) in Company |
| 4th Jun 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 20th May 2026 1:14 pm | RNS | Result of AGM |
| 20th May 2026 7:00 am | RNS | AGM Statement |
| 15th May 2026 8:02 am | RNS | Director/PDMR Shareholding |
| 14th Apr 2026 9:27 am | RNS | Annual Financial Report |
| 25th Mar 2026 2:05 pm | RNS | Director/PDMR Shareholding |